Travaux scientifiques

Prof. Dr. Nedim Turan

110 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer?

    Medicina, 2024

    DOI 10.3390/medicina60081372 PMID 39202652 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  2. Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-World Study

    Medicina, 2024

    DOI 10.3390/medicina60071088 PMID 39064516 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  3. Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer: A Promising Strategy for Enhanced Progression-Free Survival Post Ado-Trastuzumab Emtansine Progression

    Medicina, 2024

    DOI 10.3390/medicina60122069 PMID 39768949 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  4. Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive Therapy

    Cureus, 2024

    DOI 10.7759/cureus.63362 PMID 39070363 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  5. Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer

    Medicina, 2024

    DOI 10.3390/medicina60060951 PMID 38929568 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  6. Prognostic scores in pulmonary large cell neuroendocrine carcinoma: A retrospective cohort study

    Heliyon, 2024

    DOI 10.1016/j.heliyon.2024.e25029 PMID 38317875 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  7. Efficacy and Safety of Ixabepilone in Metastatic Breast Cancer After Multiple Treatments: Analysis Based on Real-World Data

    Journal of Oncological Sciences, 2024

    DOI 10.37047/jos.2024-102164 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  8. Association of Hepatitis-B virus infection status with survival and treatment response in non-small cell lung cancer patients on anti‐pd‐1/pd-l1 therapy

    Journal of Global Antimicrobial Resistance, 2024

    DOI 10.1016/j.jgar.2024.10.248 Texte intégral en libre accèsSource : OpenAlex

  9. Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older

    2024

    DOI 10.20944/preprints202409.0812.v1 Texte intégral en libre accèsSource : ORCID

  10. Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group

    International Journal of Gynecological Cancer, 2024

    DOI 10.1136/ijgc-2024-005419 PMID 38950923 5 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  11. What alters prognosis in patients who were operated for lung cancer with lymph node metastasis?

    ANZ Journal of Surgery, 2024

    DOI 10.1111/ans.19177 PMID 39205444 1 citation (OpenAlex) Source : OpenAlex

  12. Which Labarotory Index is Better for Predicting Survival and Pathological Response in Patients with Breast Cancer Receiving NACT?

    Research Square, 2024

    DOI 10.21203/rs.3.rs-3854249/v1 Texte intégral en libre accèsSource : ORCID

  13. Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience

    World journal of urology, 2023

    DOI 10.1007/s00345-023-04482-0 PMID 37351618 3 citations (Europe PMC) Source : Europe PMC

  14. Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?

    Medicina Lithuania, 2023

    DOI 10.3390/medicina59030557 PMID 36984558 12 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  15. Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data

    Pancreas, 2023

    DOI 10.1097/mpa.0000000000002238 PMID 37816170 2 citations (Europe PMC) Source : ORCID

  16. The association of hemoglobin/red blood distribution width with overall survival: a retrospective analysis of melanoma

    Esperienze Dermatologiche, 2023

    DOI 10.23736/s1128-9155.23.00556-3 1 citation (OpenAlex) Source : OpenAlex

  17. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center’s experience

    Journal of Chemotherapy, 2021

    DOI 10.1080/1120009x.2021.1923153 PMID 34032198 6 citations (Europe PMC) Source : OpenAlex

  18. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?

    Journal of Oncology Pharmacy Practice, 2021

    DOI 10.1177/10781552211015762 PMID 33961521 10 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  19. Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer

    Journal of Oncology Pharmacy Practice, 2021

    DOI 10.1177/1078155220924088 PMID 32423326 8 citations (Europe PMC) Source : ORCID

  20. Merkel cell carcinoma in Turkey: A multicentric study

    Journal of Cancer Research and Therapeutics, 2021

    DOI 10.4103/jcrt.jcrt_950_19 PMID 34916389 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  21. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?

    Current Problems in Cancer, 2020

    DOI 10.1016/j.currproblcancer.2020.100670 PMID 33129567 1 citation (Europe PMC) Source : OpenAlex

  22. Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.

    PubMed, 2019

    PMID 31786850 1 citation (Europe PMC) Source : OpenAlex

  23. Outcome of non-metastatic male breast cancer: 222 patients

    Annals of Oncology, 2019

    DOI 10.1093/annonc/mdz240.024 Texte intégral en libre accèsSource : OpenAlex

  24. Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study

    Journal of B U on, 2019

    Source : ORCID

  25. P3.01-33 EGFR Mutation in Patients with NSCLC and Its Relationship Between Survival and Clinicopathological Features: An Update Analysis

    Journal of Thoracic Oncology, 2018

    DOI 10.1016/j.jtho.2018.08.1593 Texte intégral en libre accèsSource : OpenAlex

  26. Retrospective evaluation of patients diagnosed solid pseudopapillary neoplasms of the pancreas

    Current Problems in Cancer, 2018

    DOI 10.1016/j.currproblcancer.2018.06.014 PMID 30104029 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  27. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors

    World Journal of Urology, 2017

    DOI 10.1007/s00345-016-1964-6 PMID 27812752 10 citations (Europe PMC) Source : ORCID

  28. EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e15028 Texte intégral en libre accèsSource : OpenAlex

  29. Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors

    Journal of Clinical Oncology, 2016

    DOI 10.1200/jco.2016.34.15_suppl.e16051 Source : ORCID

  30. Prognostic Factors in Stage III Non-Small-Cell Lung Cancer Patients

    Asian Pacific Journal of Cancer Prevention, 2016

    DOI 10.22034/apjcp.2016.17.10.4693 PMID 27893199 22 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  31. Prognostic factors in stage III non-small-cell lung cancer patients

    Asian Pacific Journal of Cancer Prevention, 2016

    DOI 10.7314/apjcp.2016.17.10.4693 Source : ORCID

  32. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors

    Tumor Biology, 2015

    DOI 10.1007/s13277-015-3589-6 PMID 26026587 5 citations (Europe PMC) Source : OpenAlex

  33. The prognostic value of lymph node ratio in patients with curatively resected pancreatic adenocarcinoma.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e15238 Texte intégral en libre accèsSource : OpenAlex

  34. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma

    Journal of B U on, 2015

    PMID 25778307 22 citations (OpenAlex) Source : ORCID

  35. Gastro-bronchial Fistula, an Uncommon Complication of Transhital Esophagectomy: A Case Report

    Van Yüzüncü Yıl University Academic Data Management System, 2015

    DOI 10.12691/ajcp-3-6-1 Texte intégral en libre accèsSource : OpenAlex

  36. Lomber Omurgaya Yayılan Bir Glioblastoma Multiforme Olgusu

    DergiPark (Istanbul University), 2015

    Source : OpenAlex

  37. Prognostic Factors and Adjuvant Treatments for Surgically Treated Cancers of the Biliary Tract: A Multicentre Study of the Anatolian Society of Medical Oncology (ASMO)

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.22.9687 PMID 25520089 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  38. Impact of Adjuvant Treatment Modalities on Survival Outcomes in Curatively Resected Pancreatic and Periampullary Adenocarcinoma

    Annals of Oncology, 2014

    DOI 10.1093/annonc/mdu334.79 PMID 26361410 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  39. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer

    Thoracic Cancer, 2014

    DOI 10.1111/1759-7714.12107 PMID 26763794 7 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  40. Multicenter epidemiologic study on hepatocellular carcinoma in Turkey

    Asian Pacific Journal of Cancer Prevention, 2014

    DOI 10.7314/apjcp.2014.15.6.2923 PMID 24761926 17 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  41. The role of positron emission tomography with 18F-fluorodeoxyglucose in nodal staging of clinical and radiological N0 head and neck cancers

    European Archives of Oto-Rhino-Laryngology, 2013

    DOI 10.1007/s00405-012-2337-4 PMID 23283243 14 citations (Europe PMC) Source : OpenAlex

  42. Prognostic Factors for Lymph Node Negative Stage I and IIA Non-small Cell Lung Cancer: Multicenter Experiences

    Asian Pacific Journal of Cancer Prevention, 2013

    DOI 10.7314/apjcp.2013.14.11.6287 PMID 24377519 12 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  43. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e14533 1 citation (OpenAlex) Source : OpenAlex

  44. Retrospective analysis of 178 patients with stage I rectum cancer.

    Journal of Clinical Oncology, 2013

    DOI 10.1200/jco.2013.31.15_suppl.e14662 Texte intégral en libre accèsSource : OpenAlex

  45. A patient with pleural effusion related to dasatinib,Dasatinib ılişkili plevral efüzyonlu bir hasta

    Erciyes Tip Dergisi, 2013

    DOI 10.5152/etd.2012.41 1 citation (OpenAlex) Texte intégral en libre accèsSource : ORCID

  46. Plasma Concentrations of Some Trace Element and Heavy Metals in Patients with Metastatic Colon Cancer

    Journal of Cancer Therapy, 2013

    DOI 10.4236/jct.2013.46124 24 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  47. Large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey

    Thoracic Cancer, 2012

    DOI 10.1111/j.1759-7714.2012.00129.x PMID 28920204 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  48. Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer

    Oncology, 2012

    DOI 10.1159/000342429 PMID 23076023 16 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  49. XELOX versus FOLFOX4 as Second Line Chemotherapy in Advanced Pancreatic Cancer

    Hepatogastroenterology, 2012

    DOI 10.5754/hge12181 PMID 22534542 20 citations (Europe PMC) Source : OpenAlex

  50. Front & Back Matter

    Oncology, 2012

    DOI 10.1159/000345789 Source : OpenAlex